Skip to main navigation
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
VectivBio

VectivBio

Transforming Lives

Site - Header Menu

  • About Us
    • Management Team
    • Board Members
    • Investors
    • Partners
  • Our Focus
    • Our Science
    • Our Pipeline
    • Our Clinical Trials
  • Investors & Media
    • Overview
    • News & Media
    • Events & Presentations
    • Annual General Meeting
    • Extraordinary General Meeting
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Shareholder Resources
  • Contact Us
    • Careers

SEC Filings

Filing date Form Description Filing Group View
May 22, 2023 SC TO-C

Written public communication relating to an issuer or third party tender offer

Mergers & Acquisitions
0001104659-23-063212.pdf
0001104659-23-063212.rtf
0001104659-23-063212.xls
View HTML
May 10, 2023 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001193125-23-140713.pdf
0001193125-23-140713.rtf
0001193125-23-140713.xls
View HTML
Apr 19, 2023 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001193125-23-105780.pdf
0001193125-23-105780.rtf
0001193125-23-105780.xls
View HTML
Apr 19, 2023 20-F

Registration of securities of foreign private issuers pursuant to section 12(b) or (g)

Annual Filings
0000950170-23-013373.pdf
0000950170-23-013373.rtf
0000950170-23-013373.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Apr 6, 2023 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001193125-23-094107.pdf
0001193125-23-094107.rtf
0001193125-23-094107.xls
View HTML
Feb 24, 2023 EFFECT

EFFECT

Other
9999999995-23-000474.pdf
9999999995-23-000474.rtf
9999999995-23-000474.xls
View HTML
Feb 22, 2023 CORRESP

CORRESP

Other
0001193125-23-044795.pdf
0001193125-23-044795.rtf
0001193125-23-044795.xls
View HTML
Feb 14, 2023 SC 13G/A

An amendment to the SC 13G filing

Other
0001104659-23-020824.pdf
0001104659-23-020824.rtf
View HTML
Feb 14, 2023 SC 13G/A

An amendment to the SC 13G filing

Other
0001580642-23-000870.pdf
0001580642-23-000870.rtf
0001580642-23-000870.xls
View HTML
Feb 14, 2023 SC 13G/A

An amendment to the SC 13G filing

Other
0000929638-23-000553.pdf
0000929638-23-000553.rtf
0000929638-23-000553.xls
View HTML

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

Primary Sidebar

INVESTORS & MEDIA

  • Overview
  • News & Media
    • Press Releases
  • Events & Presentations
  • Annual General Meeting
  • Extraordinary General Meeting
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Reports
  • Stock Information
    • Historical Stock Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board Members
    • Committee Composition
  • Shareholder Resources
    • FAQs
    • Email Alerts
    • Contact IR
    • RSS Feeds

Site - Shareholder Tools

Email Alerts Print Search

IR CONTACT

ir@vectivbio.com

 

Footer

Site - Footer Menu Left

VectivBio

Site - Footer Menu Center

Terms of Use Privacy Policy

Copyright © VectivBio AG, 2023. All Rights Reserved.

Site - Footer Menu Right

  • About Us
  • Our Focus
  • Investors & Media
  • Contact Us

Site - Header Menu

  • About Us
    • Management Team
    • Board Members
    • Investors
    • Partners
  • Our Focus
    • Our Science
    • Our Pipeline
    • Our Clinical Trials
  • Investors & Media
    • Overview
    • News & Media
    • Events & Presentations
    • Annual General Meeting
    • Extraordinary General Meeting
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Shareholder Resources
  • Contact Us
    • Careers